Om

NeuroThera Labs Inc. is a clinical-stage pharmaceutical company focused on developing therapies for central nervous system disorders and other underserved health conditions. The company’s current programs center on cannabinoid-based and related pharmaceutical approaches, including treatments being explored for Tourette syndrome, Alzheimer’s disease and agitation, autism spectrum disorder, and status epilepticus. It also works on transcranial photobiomodulation, a light-based neurotherapy platform designed to target brain regions with near-infrared technology. NeuroThera Labs Inc. operates in the specialty biotech and drug development market, where it combines research collaborations and innovative drug combinations to address complex neurological and psychiatric indications. The company is headquartered in Vancouver, Canada, and is positioned as a focused developer of novel medical technologies for highly specialized treatment areas.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I NEUROTHERA LABS MED ENDAVU: Køb NeuroThera Labs ($NTLX) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i NeuroThera Labs, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.